Articles tagged "Mortality"

2016 American Transplant Congress
Serum Bicarbonate and Long-Term Outcomes in Kidney Transplant Recipients.
S. Park,¹ E. Kang,¹ M. Han,¹ J. Park,¹ S. Yang,² S. Park,³ I. Jung,⁴ C. Lim,⁵ Y. Kim,¹ Y. Kim,⁶ J. Lee.⁵
¹Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; ²Kidney Research Institute, Seoul National University College of Medicine, Seoul, Korea; ³Department of Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea; ⁴Department of Surgery, Seoul National University Boramae Medical Center, Seoul, Korea; ⁵Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; ⁶Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea.
Background: Metabolic acidosis indicated by low serum bicarbonate (TCO2) level has been known as a risk factor for mortality and progressive renal dysfunction in patients…
2016 American Transplant Congress
A 15-Year Retrospective Analysis of Acute Kidney Injury in Non Renal Solid Organ Transplant Recipients: Incidence, Outcome and Progression Toward End Stage Chronic Kidney Disease.
V. Cantaluppi,¹ A. Quercia,² S. Dellepiane,² D. Medica,² L. Biancone.²
¹Nephrology, Dialysis and Kidney Transplantation Unit, University of Eastern Piedmont "A. Avogadro", Novara, Italy; ²Nephrology, Dialysis and Kidney Transplantation Unit, University of Torino, Torino, Italy.
Acute kidney injury (AKI) is a frequent complication in critically ill patients admitted to Intensive Care Units, often complicated by high mortality and progression toward…
2016 American Transplant Congress
Early Hospital Readmission After Kidney Transplantation: Seasonality, Causes and Prognosis.
M. Tavares, M. Cristelli, L. Viana, M. de Paula, H. Silva Junior, J. Medina Pestana.
Nephrology Division, Hospital do Rim Foundation, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.
Background: In the general population, 30-day hospital readmission rate is a well-accepted quality metric and a predictor of mortality. A growing body of data suggests…
2016 American Transplant Congress
Predicting Survival to Listing for Liver Transplantation: Do MELD and Race Interact?
M. Jesse, E. Goldstein, N. Rebhan, C.-X. Ho, T. Macaulay, M. Bebanic, L. Shkokani, D. Moonka, M. Abouljoud, A. Yoshida.
Transplant Institute, Henry Ford Health System, Detroit.
Minimal research has been focused on the evaluation process for liver transplant listing. The purpose of this study was to examine whether evaluation MELD score…
2016 American Transplant Congress
Factors Affecting Mortality During Waiting Time for Kidney Transplantation: A Nationwide Population-Based Cohort Study Using the Korean Network for Organ Sharing (KONOS) Database.
S. Lee,¹ K. Yoo,² J. An,³ Y. Oh,³ C. Lim,³ Y. Kim,¹ J. Lee.³
¹Seoul National University Hospital, Seoul, Republic of Korea; ²Dongguk University Medical Center, Gyeongju, Republic of Korea; ³Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Background: Longer waiting times for kidney transplant have been suggested to be more deleterious than shorter waiting times. We analyzed the impact of waiting time…
2016 American Transplant Congress
Survival Benefit of Kidney Transplantation in US Adults with Sickle Cell Nephropathy.
T. Purnell, X. Luo, S. Bae, A. Massie, D. Segev.
Johns Hopkins, Baltimore.
End-stage renal disease (ESRD) patients with sickle cell nephropathy (SCN) are less likely to receive a kidney transplant (KT) than ESRD patients without SCN. Comparing…
2016 American Transplant Congress
Hepatitis B Reactivation Among Non-Liver Solid Organ Transplant Recipients.
A. Gonzalez, F. Forouton, A. Humar, S. Husain.
Multi-Organ Transplant Program, Transplant Infectious Diseases, University Health Network, University of Toronto, Toronto, ON, Canada.
IntroductionThe purpose of this study was to evaluate the incidence of post-transplant hepatitis B (HBV) reactivation in patients who have previously cleared hepatitis B surface…
2016 American Transplant Congress
The Impact of Donor Origin on Survival after Orthotopic Heart Transplantation.
O. Kiamanesh, A. Khosla, C. Imai, E. Johansson, S. Virani, M. Davis, A. Cheung, J. Bashir, B. Munt, A. Ignaszewski, A. Kaan, M. Toma.
University of British Columbia, Vancouver, BC, Canada.
BackgroundOrthotopic heart transplantation (OHT) is the gold standard for the management of select patients with end-stage heart failure, but limited by an ongoing organ donor…
2016 American Transplant Congress
Trends in Aspergillus Infection After Liver Transplantation, 1988-2014.
R. Al Masri, L. Jennings, S. Asrani, G. Klintmalm, C. Spak.
Transplant Hepatology/Transplant Surgery/Infectious Disease, Baylor University Medical Center, Dallas, TX.
Background: Invasive Aspergillosis is an important cause of morbidity and mortality in liver transplant recipients. Aspergillus may account for up to 25% of all fungal…
2016 American Transplant Congress
Liver Recipient with Renal Dysfunction: Liver Only or Simultaneous Liver-Kidney Transplant?
K. Yadav, T. Pruett, R. Kandaswamy, W. Payne, L. Zhang, S. Chinnakotla.
University of Minnesota, Minneapolis, MN.
Background: The OPTN listing criteria for Simultaneous liver-kidney transplant (SLK) are not well defined. There are concerns about rising numbers of SLKs, which take kidneys…